![Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-9560-11-10/MediaObjects/12959_2013_Article_185_Fig1_HTML.jpg)
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text
![Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/0a1b965e-4e95-4c3e-8621-b2ad1de72793/28ga01.jpg)
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
![Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram](https://www.researchgate.net/profile/Irene-Predazzi/publication/236090583/figure/fig1/AS:601591971315727@1520442111483/Mechanism-of-action-of-warfarin-dabigatran-rivaroxaban-and-apixaban-in-relation-to-the.png)
Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram
![Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2014/05/drugs-on-factoe-xa.jpeg)
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram](https://www.researchgate.net/profile/James-Gagg/publication/281235144/figure/fig1/AS:284620739366923@1444870280861/Mechanism-of-action-of-the-non-vitamin-K-antagonist-oral-anticoagulants-NOACs-Anti-Xa_Q320.jpg)
Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram
![Pharmacology and mechanisms of action of new oral anticoagulants - Salem - 2015 - Fundamental & Clinical Pharmacology - Wiley Online Library Pharmacology and mechanisms of action of new oral anticoagulants - Salem - 2015 - Fundamental & Clinical Pharmacology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f39850bf-e402-4b52-b93f-70052eadd290/fcp12091-fig-0001-m.jpg)
Pharmacology and mechanisms of action of new oral anticoagulants - Salem - 2015 - Fundamental & Clinical Pharmacology - Wiley Online Library
![Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/newsletters/2017/Oct/images/NOAC_FIG2.png)
Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation
![New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109712005037-gr1.jpg)
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect
![The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2002825672/2010325326/gr1.jpg)
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research
![Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2014/05/eliquis-2.jpg)
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/14/2/278/F2.large.jpg)
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
![Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile Fazeel Z A - MAMC J Med Sci Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile Fazeel Z A - MAMC J Med Sci](https://www.mamcjms.in/articles/2016/2/2/images/MAMCJMedSci_2016_2_2_63_182723_f1.jpg)
Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile Fazeel Z A - MAMC J Med Sci
![PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/64d620321dfe4fcc85537c0e0a6f9260a019b8fa/2-Figure1-1.png)